Literature DB >> 9973429

Activated T cells acquire endothelial cell surface determinants during transendothelial migration.

R I Brezinschek1, N Oppenheimer-Marks, P E Lipsky.   

Abstract

Activated T cells acquire endothelial cell (EC) plasma membrane constituents during transendothelial migration. This was assessed using an in vitro model system in which human peripheral blood CD4+ T cells migrated through confluent monolayers of HUVEC. Flow cytometry of migrated CD4+ T cells demonstrated that activated, but not resting, T cells acquired a variety of endothelial surface determinants, including CD31, CD49d, CD54, CD61, and CD62E. The extracellular domains of these molecules were detected on migrated T cells with mAbs, including those directed to the ligand-binding regions. A number of approaches were employed to document that the acquisition of these molecules was uniquely accomplished by activated T cells and clearly involved transfer from both resting and TNF-alpha-activated EC. Acquisition of endothelial markers by activated T cells occurred as part of the transfer of membrane components, as migrating T cells acquired EC membranes prelabeled with the lipophilic dye, 3,3'-dihexadecyloxacarbocyanine perchlorate (DiOC-16), along with EC surface proteins. Thus, during transendothelial migration, activated T cells acquire endothelial membrane components, and as a result may deliver them to perivascular sites.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973429

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  The percentage of CD31+ T cells decreases after open but not laparoscopic surgery.

Authors:  I Kirman; V Cekic; N Poltaratskaia; Z Asi; S Conte; D Feingold; K A Forde; E H Huang; R L Whelan
Journal:  Surg Endosc       Date:  2003-03-07       Impact factor: 4.584

2.  Trypanosoma cruzi invasion is associated with trogocytosis.

Authors:  Shankar Mukherjee; Aparna Mukhopadhyay; Grasiella Andriani; Fabiana Simão Machado; Anthony W Ashton; Huan Huang; Louis M Weiss; Herbert B Tanowitz
Journal:  Microbes Infect       Date:  2014-11-04       Impact factor: 2.700

3.  Increased transendothelial migration of scleroderma lymphocytes.

Authors:  G H Stummvoll; M Aringer; J Grisar; C W Steiner; J S Smolen; R Knobler; W B Graninger
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

Review 4.  Receptor-mediated T cell absorption of antigen presenting cell-derived molecules.

Authors:  Inkyu Hwang; DaLim Ki
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

5.  Extracellular-regulated kinase activation and CAS/Crk coupling regulate cell migration and suppress apoptosis during invasion of the extracellular matrix.

Authors:  S Y Cho; R L Klemke
Journal:  J Cell Biol       Date:  2000-04-03       Impact factor: 10.539

6.  Phenotypic characteristics of human monocytes undergoing transendothelial migration.

Authors:  J Grisar; P Hahn; S Brosch; M Peterlik; J S Smolen; P Pietschmann
Journal:  Arthritis Res       Date:  2001-01-11

7.  1,25-Dihydroxyvitamin D3 Restrains CD4+ T Cell Priming Ability of CD11c+ Dendritic Cells by Upregulating Expression of CD31.

Authors:  Louise Saul; Iris Mair; Alasdair Ivens; Pamela Brown; Kay Samuel; John D M Campbell; Daniel Y Soong; Nadine Kamenjarin; Richard J Mellanby
Journal:  Front Immunol       Date:  2019-03-28       Impact factor: 7.561

Review 8.  Intercellular transfer of MHC and immunological molecules: molecular mechanisms and biological significance.

Authors:  L A Smyth; B Afzali; J Tsang; G Lombardi; R I Lechler
Journal:  Am J Transplant       Date:  2007-06       Impact factor: 8.086

Review 9.  Mechanisms of cellular communication through intercellular protein transfer.

Authors:  Khawaja Ashfaque Ahmed; Jim Xiang
Journal:  J Cell Mol Med       Date:  2010-01-11       Impact factor: 5.310

Review 10.  T cell regeneration after immunological injury.

Authors:  Enrico Velardi; Jennifer J Tsai; Marcel R M van den Brink
Journal:  Nat Rev Immunol       Date:  2020-10-23       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.